Saving changes...

Done

Error

Why do we need new options for managing FH?

Why do we need new options for managing FH?

Why do we need new options for managing FH?

Atul Kalhan - Vinay Eligar - Alan Rees
Atul Kalhan - Vinay Eligar - Alan Rees
on behalf of the Primary Care Cardiovascular Journal and the British Journal of Primary Care Nursing

$12.97 $ 12.97 $ 12.97

$12.97 $ 12.97 $ 12.97

$ 12.97 $ 12.97 $ 12.97
$ 12.97 $ 12.97 $ 12.97
Normal Price: $12.97 $12.97

Review:

Launch date: 11 Apr 2018
Expiry Date:

Last updated: 23 Aug 2018

Reference: 187911

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

In patients with both homozygous and heterozygous familial hypercholesterolaemia (FH), statins with or without ezetimibe are now the mainstay pharmacological therapy for lowering low-density lipoprotein cholesterol (LDL-C) levels, combined with lipoprotein apheresis in homozygotes and statin-refractory heterozygotes. These therapies have helped to improve outcomes, but new treatment options are urgently needed, as FH patients continue to be at high risk of premature death due to cardiovascular disease (CVD).

This CPD module was published 19 Aug 2014 for a UK audience. Although the information contained within the module is still deemed relevant and guidelines correct. Studies, products, practices and data may have been updated since date of publication and Guidelines and practices in other countries may differ from those in the UK. Readers are advised to check their local guidance and product specifications

Objectives

On completion of this course, the learner will gain further understanding of:
Homozygous and heterozygous familial hypercholesterolaemia (FH)
Atul Kalhan - Vinay Eligar - Alan Rees

Author Information Play Video Bio

Atul Kalhan - Vinay Eligar - Alan Rees
on behalf of the Primary Care Cardiovascular Journal and the British Journal of Primary Care Nursing

PCCJ and BJPCN are digital platforms for primary care nurses, GPs and other healthcare professionals with a specific interest in cardiovascular disease, diabetes and related disorders.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error